Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 28, 2022 06:00 ET | Source: Unicyte AG

Unicyte AG, a Leader in Stem Cell Therapy Innovation, Advances Lead Program to Phase 2 Clinical Development

— Submits Clinical Trial Application for potentially life-saving therapy for pediatric patients with urea cycle disorders, setting the stage for patient enrollment in H2 2022 — OBERDORF NW,...